Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$8.24 - $12.97 $191,168 - $300,904
23,200 New
23,200 $195,000
Q4 2022

Feb 13, 2023

BUY
$14.16 - $24.02 $69,695 - $118,226
4,922 Added 43.56%
16,222 $242,000
Q3 2022

Nov 07, 2022

BUY
$18.07 - $31.37 $204,191 - $354,481
11,300 New
11,300 $252,000
Q1 2022

May 16, 2022

SELL
$20.26 - $32.36 $2,026 - $3,236
-100 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$26.0 - $37.03 $122,200 - $174,041
-4,700 Reduced 97.92%
100 $3,000
Q3 2021

Nov 09, 2021

BUY
$29.75 - $37.99 $142,800 - $182,352
4,800 New
4,800 $151,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $780M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.